Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 4/20 | 0.48 |
| ▸ | CCR8 | P51685 | 4/20 | 0.48 |
| ▸ | CCR5 | P51681 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | MMP2 | P08253 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | MMP8 | P22894 | 1/20 | 0.48 |
| ▸ | THPO | P40225 | 1/20 | 0.48 |
| ▸ | MTOR | P42345 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6046239 | 0.79 | METAP2 (0.46) | CCR1CCR5KDM4ETSHRSMN1; SMN2 | |
| SCHEMBL30184687 | 0.75 | CCR1 (0.75) | CCR1CCR8CCR5KDM4EMMP2 | |
| SCHEMBL1282008 | 0.75 | CCR1 (0.75) | CCR1CCR8CCR5KDM4EMMP2 | |
| SCHEMBL9673747 | 0.74 | ALDH1A1 (0.44) | KDM4ETSHRLMNAMAPTALOX15 | |
| SCHEMBL28592779 | 0.73 | CCR1 (0.48) | CCR1CCR8CCR5KDM4EMMP2 | |
| SCHEMBL30374174 | 0.73 | CCR1 (0.48) | CCR1CCR8CCR5KDM4EMMP2 | |
| SCHEMBL19596533 | 0.73 | MMP2 (0.38) | CCR1CCR8CCR5KDM4EMMP2 | |
| SCHEMBL12853981 | 0.72 | LMNA (0.68) | CCR1CCR8CCR5KDM4EMMP2 | |
| SCHEMBL5696379 | 0.72 | SLC6A3 (0.41) | KDM4ETSHRMAPTALOX15SMN1; SMN2 | |
| SCHEMBL28006187 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101098899-B | Polyethylene and catalyst composition for its preparation | BASELL POLYOLEFINE GMBH | 2011-04-13 | — | — | CN | disclosed |
| CN-101824111-A | Polyethylene and the catalyst composition that is used for its preparation | BASELL POLYOLEFINE GMBH | 2010-09-08 | — | — | CN | disclosed |
| CN-101098899-A | Polyethylene and catalyst composition for its preparation | BASELL POLYOLEFINE GMBH (DE) | 2008-01-02 | — | — | CN | disclosed |
| EP-1370532-B1 | METHOD FOR PRODUCING CYCLOPENTADIENE COMPOUNDS | BASELL POLYOLEFINE GMBH (DE) | 2006-05-17 | — | — | EP | disclosed |
| US-6995267-B2 | Method for producing cyclopentadiene compounds | BASELL POLYOLEFINE GMBH (DE) | 2006-02-07 | — | — | US | disclosed |
| US-20040097749-A1 | Method for producing cyclopentadiene compounds | EQUISTAR CHEMICALS, LP | 2004-05-20 | — | — | US | disclosed |
| EP-1370532-A1 | METHOD FOR PRODUCING CYCLOPENTADIENE COMPOUNDS | Basell Polyolefine GmbH (DE) | 2003-12-17 | — | — | EP | disclosed |
| WO-2002074745-A1 | METHOD FOR PRODUCING CYCLOPENTADIENE COMPOUNDS | BASELL POLYOLEFINE GMBH (DE) | 2002-09-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097749-A1 | Method for producing cyclopentadiene compounds | DHPS, FDPS, CYCS | CCR1 1925/4885CCR8 1441/4885CCR5 304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.